<bill session="118" type="s" number="993" updated="2025-11-19T03:38:52Z">
  <state datetime="2023-03-28">REFERRED</state>
  <status>
    <introduced datetime="2023-03-28"/>
  </status>
  <introduced datetime="2023-03-28"/>
  <titles>
    <title type="display">Combating Illicit Xylazine Act</title>
    <title type="short" as="introduced">Combating Illicit Xylazine Act</title>
    <title type="official" as="introduced">A bill to prohibit certain uses of xylazine, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C001113"/>
  <cosponsors>
    <cosponsor bioguide_id="B001277" joined="2023-09-26"/>
    <cosponsor bioguide_id="B001236" joined="2023-07-20"/>
    <cosponsor bioguide_id="B001319" joined="2023-07-18"/>
    <cosponsor bioguide_id="B000944" joined="2023-06-15"/>
    <cosponsor bioguide_id="C000127" joined="2024-01-22"/>
    <cosponsor bioguide_id="C001047" joined="2023-03-28"/>
    <cosponsor bioguide_id="C001070" joined="2023-07-18"/>
    <cosponsor bioguide_id="G000555" joined="2023-05-04"/>
    <cosponsor bioguide_id="G000386" joined="2023-03-28"/>
    <cosponsor bioguide_id="H001076" joined="2023-03-28"/>
    <cosponsor bioguide_id="H001079" joined="2023-06-01"/>
    <cosponsor bioguide_id="K000384" joined="2023-07-27"/>
    <cosponsor bioguide_id="K000377" joined="2023-04-20"/>
    <cosponsor bioguide_id="K000367" joined="2023-07-11"/>
    <cosponsor bioguide_id="L000570" joined="2023-07-20"/>
    <cosponsor bioguide_id="M001183" joined="2023-03-28"/>
    <cosponsor bioguide_id="M001198" joined="2023-03-28"/>
    <cosponsor bioguide_id="R000584" joined="2023-03-28"/>
    <cosponsor bioguide_id="R000608" joined="2023-07-12"/>
    <cosponsor bioguide_id="R000605" joined="2023-05-04"/>
    <cosponsor bioguide_id="R000595" joined="2023-07-11"/>
    <cosponsor bioguide_id="S001217" joined="2023-06-15"/>
    <cosponsor bioguide_id="S001181" joined="2023-03-28"/>
    <cosponsor bioguide_id="S000770" joined="2023-07-11"/>
    <cosponsor bioguide_id="T000250" joined="2023-05-30"/>
    <cosponsor bioguide_id="T000476" joined="2023-09-07"/>
    <cosponsor bioguide_id="V000137" joined="2023-07-27"/>
    <cosponsor bioguide_id="W000805" joined="2023-09-05"/>
    <cosponsor bioguide_id="W000437" joined="2023-07-11"/>
    <cosponsor bioguide_id="Y000064" joined="2023-07-12"/>
  </cosponsors>
  <actions>
    <action datetime="2023-03-28">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-03-28" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
    <action datetime="2024-01-11">
      <text>Committee on Banking, Housing, and Urban Affairs. Hearings held.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSBK" name="Senate Banking, Housing, and Urban Affairs" subcommittee="" activity="Hearings By (Full Committee)"/>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="1839" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Congressional oversight"/>
    <term name="Criminal procedure and sentencing"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Manufacturing"/>
    <term name="Retail and wholesale trades"/>
    <term name="Veterinary medicine and animal diseases"/>
  </subjects>
  <amendments/>
  <summary date="2023-10-04T19:48:26Z" status="Introduced in Senate">Combating Illicit Xylazine Act

This bill criminalizes the illicit use of xylazine. (Xylazine, also known as Tranq, is a sedative that is approved for use in animals. The Drug Enforcement Administration (DEA) has reported an increase in the trafficking of fentanyl mixed with xylazine.)

Specifically, the bill establishes criminal penalties for manufacturing, distributing, or dispensing, or possessing with intent to manufacture, distribute, or dispense, xylazine for illicit use (i.e., for use in humans) in accordance with the penalties for schedule III substances (up to 10 years imprisonment or, if death or serious bodily injury occurs, up to 15 years imprisonment, as well as criminal fines).

In addition, the DEA must coordinate with the Food and Drug Administration to report on the prevalence of the illicit use of xylazine, including associated supply chains. The bill also declares the illicit use of xylazine as an emerging drug threat.</summary>
</bill>
